Considered the shock troops of the immune system, natural killer (NK) cells are the first wave of defenders against infection and disease. Researchers – including Dana-Farber Cancer Institute’s Rizwan Romee, MD – are discovering the unique capabilities of NK cells that give them potential as a potent cancer therapy. Listen to a discussion with Dr. Romee and his Dana-Farber colleagues Glenn Hanna, MD, and Sarah Nikiforow, MD, PhD, about Dana-Farber’s NK cell research to learn more about the immense promise this therapy has for future patients across several cancer types including hematologic, head and neck, and ovarian cancers. The virtual discussion was moderated by Robert Soiffer, MD.
To learn more, visit the Revolutionary Science section of this site.